Semaglutide May Cut Cardiovascular Risk Before Weight Loss
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or full dosing was achieved.
Related Articles
Are US Cervical Cancer Screening Exit Criteria Failing?
A new modeling study estimates that the risk for cervical cancer is low in women who met criteria to stop screening, but real-world stats tell…
Doctors With Anxiety Disorders Say Break Silence, Get Help
Too many physicians quietly battle anxiety and panic disorders. These doctors say treatment and openness saved their careers and changed their lives.
Hey, Hospitalists, Those Hoofbeats Sometimes May Be a Zebra
Hospitalists have to make decisions based on experience and common knowledge, but sometimes there is something else at play.
Doc: ‘I Forgot I Was 7000 Miles Away’ During Surgical First
In a telemedicine advance, a surgeon in Cleveland performed robotic prostate surgery on a patient in the United Arab Emirates.
Bariatric Surgery More Effective and Durable Than New Obesity Drugs and Lifestyle Intervention
SAN DIEGO – June 11, 2024 – Systematic reviews* of medical literature between 2020 to 2024 show bariatric surgery, also known as metabolic or weight-loss…
Amiloride Noninferior to Spironolactone for Resistant Hypertension
Amiloride is as effective as spironolactone in lowering home-measured systolic blood pressure in patients with resistant hypertension, offering a potential alternative treatment.
From Hindrance to Help: The Test of ‘My Person’ in the ICU
Family members and patients’ private caregivers can either be helpful or harmful in the ICU. You have the opportunity to decide which.
Gut microbiota-derived short-chain fatty acids and their role in human health and disease
Nature Reviews Microbiology – The human intestinal microbiota ferments dietary fibre to short-chain fatty acids, which make an important contribution to host health. In this…
GLP-1RA in the Real World: 1-year Compliance and Outcomes… : Annals of Surgery
e to factors such as costs, drug availability, insurance coverage, and adverse events. Methods: A retrospective series of patients with obesity prescribed semaglutide at a…
Postoperative Outcomes in Super- and Super-Super Obese Patients Undergoing Emergency Abdominal Surgery
With a rising prevalence of Class III obesity (BMI >40), it is crucial to identify the perioperative risks associated with super-obesity (BMI 50-59.9) and super-super-obesity…